Difference between revisions of "List of Registered Conformant Users (Self-attestation)"
(Full Conformance Table) |
|||
Line 10: | Line 10: | ||
− | ==<font color=blue>'''QIBA | + | ==<font color=blue>'''Sites in Full Conformance to a QIBA Profile'''</font>== |
{| style="width:80%" border="1" cellpadding="3" | {| style="width:80%" border="1" cellpadding="3" | ||
! <font color=green>'''Imaging Site/Vendor/CRO'''</font> | ! <font color=green>'''Imaging Site/Vendor/CRO'''</font> | ||
− | ! <font color=green>'''QIBA Profile'''</font> | + | ! Pilot |
− | ! <font color=green>'''Conformance Term'''</font> | + | !<font color="green">'''QIBA Profile'''</font> |
+ | !<font color="green">'''Conformance Term'''</font> | ||
|- | |- | ||
− | | '''Invicro Imaging Center London''' | + | |'''Invicro Imaging Center London''' |
− | | ADC Change Profile (ver2019) | + | |QIBA-EARL I |
+ | |ADC Change Profile (ver2019) | ||
| April 8, 2020 - April 7, 2022 | | April 8, 2020 - April 7, 2022 | ||
|- | |- | ||
− | | '''Liverpool Hospital, SWS Australia''' | + | |'''Liverpool Hospital, SWS Australia''' |
− | | ADC Change Profile (ver2019) | + | |QIBA-EARL I |
+ | |ADC Change Profile (ver2019) | ||
| April 1, 2021 - April 1, 2023 | | April 1, 2021 - April 1, 2023 | ||
|- | |- | ||
− | | '''University Hospital Olomouc''' | + | |'''University Hospital Olomouc''' |
− | | FDG-PET/CT Profile (ver2016) | + | |QIBA-EARL I |
+ | |FDG-PET/CT Profile (ver2016) | ||
| February 15, 2021 - February 14, 2022 | | February 15, 2021 - February 14, 2022 | ||
|- | |- | ||
− | | '''University College London Hospital''' | + | |'''University College London Hospital''' |
− | | FDG-PET/CT Profile (ver2016) | + | |QIBA-EARL I |
+ | |FDG-PET/CT Profile (ver2016) | ||
| February 15, 2021 - February 14, 2022 | | February 15, 2021 - February 14, 2022 | ||
|- | |- | ||
− | | '''Charite University Medical Hospital Berlin''' | + | |'''Charite University Medical Hospital Berlin''' |
− | | FDG-PET/CT Profile (ver2016) | + | |QIBA-EARL I |
− | | February 15, 2021 - February 14, 2022 | + | |FDG-PET/CT Profile (ver2016) |
+ | |February 15, 2021 - February 14, 2022 | ||
|- | |- | ||
− | | '''German Oncology Center (GOC), Cyprus''' | + | |'''German Oncology Center (GOC), Cyprus''' |
− | | FDG-PET/CT Profile (ver2016) | + | |QIBA-EARL I |
− | | May 28, 2021 - May 27, 2022 | + | |FDG-PET/CT Profile (ver2016) |
+ | |May 28, 2021 - May 27, 2022 | ||
|- | |- | ||
− | | '''University Medical Center Groningen, NL''' | + | |'''University Medical Center Groningen, NL''' |
− | | FDG-PET/CT Profile (ver2016) | + | |QIBA-EARL I |
− | | May 28, 2021 - May 27, 2022 | + | |FDG-PET/CT Profile (ver2016) |
+ | |May 28, 2021 - May 27, 2022 | ||
|- | |- | ||
− | | '''University of Duisburg-Essen, Germany''' | + | |'''University of Duisburg-Essen, Germany''' |
− | | FDG-PET/CT Profile (ver2016) | + | |QIBA-EARL I |
− | | May 28, 2021 - May 27, 2022 | + | |FDG-PET/CT Profile (ver2016) |
+ | |May 28, 2021 - May 27, 2022 | ||
|- | |- | ||
− | | '''University Medical Center Amsterdam, NL''' | + | |'''University Medical Center Amsterdam, NL''' |
− | | FDG-PET/CT Profile (ver2016) | + | |QIBA-EARL I |
− | | May 28, 2021 - May 27, 2022 | + | |FDG-PET/CT Profile (ver2016) |
+ | |May 28, 2021 - May 27, 2022 | ||
|- | |- | ||
− | | '''Kobe City General Hospital (KCGH), Japan''' | + | | '''Kobe City General Hospital (KCGH), Japan''' |
− | | FDG-PET/CT Profile (ver2016) | + | |QIBA-EARL I |
− | | May 28, 2021 - May 27, 2022 | + | | FDG-PET/CT Profile (ver2016) |
+ | |May 28, 2021 - May 27, 2022 | ||
|- | |- | ||
− | | '''Klinik für Nuklearmedizin der TU München, Germany''' | + | |'''Klinik für Nuklearmedizin der TU München, Germany''' |
− | | FDG-PET/CT Profile (ver2016) | + | |QIBA-EARL I |
− | | May 28, 2021 - May 27, 2022 | + | |FDG-PET/CT Profile (ver2016) |
+ | |May 28, 2021 - May 27, 2022 | ||
|- | |- | ||
− | | '''Humanitas Istituto Clinico Catanese''' | + | |'''Humanitas Istituto Clinico Catanese''' |
− | | FDG-PET/CT Profile (ver2016) | + | |QIBA-EARL I |
− | | November 8, 2022 - November 8, 2023 | + | |FDG-PET/CT Profile (ver2016) |
+ | |November 8, 2022 - November 8, 2023 | ||
|} | |} | ||
− | ==<font color=blue>'''QIBA-EARL Pilot II -- in progress'''</font>== | + | ==<font color="blue">'''QIBA-EARL Pilot II -- in progress'''</font>== |
{| style="width:80%" border="1" cellpadding="3" | {| style="width:80%" border="1" cellpadding="3" | ||
− | ! <font color=green>'''Imaging Site/Vendor/CRO'''</font> | + | !<font color="green">'''Imaging Site/Vendor/CRO'''</font> |
− | ! <font color=green>'''QIBA Profile'''</font> | + | !<font color="green">'''QIBA Profile'''</font> |
− | ! <font color=green>'''Conformance Term'''</font> | + | !<font color="green">'''Conformance Term'''</font> |
|- | |- | ||
− | | '''CUH Alliance Medical''' | + | |'''CUH Alliance Medical''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | March 31, 2022 – March 31, 2023 | + | |March 31, 2022 – March 31, 2023 |
|- | |- | ||
− | | '''IRCCS Ospedale Policlinico San Martino di Genova''' | + | |'''IRCCS Ospedale Policlinico San Martino di Genova''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | March 31, 2022 – March 31, 2023 | + | |March 31, 2022 – March 31, 2023 |
|- | |- | ||
− | | '''Institut Claudius REGAUD''' | + | |'''Institut Claudius REGAUD''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | March 31, 2022 – March 31, 2023 | + | |March 31, 2022 – March 31, 2023 |
|- | |- | ||
− | | '''Centro PET La Milagrosa''' | + | |'''Centro PET La Milagrosa''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | March 31, 2022 – March 31, 2023 | + | |March 31, 2022 – March 31, 2023 |
|- | |- | ||
− | | '''University Hospital Regensburg''' | + | |'''University Hospital Regensburg''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | March 31, 2022 - March 31, 2023 | + | |March 31, 2022 - March 31, 2023 |
|- | |- | ||
| '''INTECNUS''' | | '''INTECNUS''' | ||
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | March 31, 2022 - March 31, 2023 | + | |March 31, 2022 - March 31, 2023 |
|- | |- | ||
− | | '''German Oncology Center (GOC), Cyprus''' | + | |'''German Oncology Center (GOC), Cyprus''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | March 31, 2022 - March 31, 2023 | + | |March 31, 2022 - March 31, 2023 |
|- | |- | ||
− | | '''Affidea – CT Clinic ''' | + | |'''Affidea – CT Clinic ''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | March 31, 2022 - March 31, 2023 | + | |March 31, 2022 - March 31, 2023 |
|- | |- | ||
− | | '''Hospital Regional Universitario de Málaga''' | + | |'''Hospital Regional Universitario de Málaga''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
|April 9, 2022 - April 9, 2023 | |April 9, 2022 - April 9, 2023 | ||
|- | |- | ||
− | | '''IDI - Unitat MN-PET Hospital Universitari de Bellvitge''' | + | |'''IDI - Unitat MN-PET Hospital Universitari de Bellvitge''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
− | |April 14, 2022 - April 14, 2023 | + | | April 14, 2022 - April 14, 2023 |
|- | |- | ||
− | | '''Affidea Warsaw 1 PET-CT Department''' | + | |'''Affidea Warsaw 1 PET-CT Department''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
− | |April 14, 2022 - April 14, 2023 | + | | April 14, 2022 - April 14, 2023 |
|- | |- | ||
− | | '''National Cancer Hospital (K hospital)''' | + | |'''National Cancer Hospital (K hospital)''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
− | |April 14, 2022 - April 14, 2023 | + | | April 14, 2022 - April 14, 2023 |
|- | |- | ||
− | | '''Klinikum rechts der Isar, Nuclear Medicine Department''' | + | |'''Klinikum rechts der Isar, Nuclear Medicine Department''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
− | |April 14, 2022 - April 14, 2023 | + | | April 14, 2022 - April 14, 2023 |
|- | |- | ||
− | | '''IRMET PET/CT Centre''' | + | |'''IRMET PET/CT Centre''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
− | |April 14, 2022 - April 14, 2023 | + | | April 14, 2022 - April 14, 2023 |
|- | |- | ||
− | | '''Semmelweis University Medical Imaging Clinic''' | + | |'''Semmelweis University Medical Imaging Clinic''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
− | |April 14, 2022 - April 14, 2023 | + | | April 14, 2022 - April 14, 2023 |
|- | |- | ||
− | | '''Centro PET La Milagrosa''' | + | |'''Centro PET La Milagrosa''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
− | |April 14, 2022 - April 14, 2023 | + | | April 14, 2022 - April 14, 2023 |
|- | |- | ||
− | | '''Lausanne University Hospital''' | + | |'''Lausanne University Hospital''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
− | |April 20, 2022 - April 20, 2023 | + | | April 20, 2022 - April 20, 2023 |
|- | |- | ||
− | | '''University Hospital dr. Peset. Valencia, Spain''' | + | |'''University Hospital dr. Peset. Valencia, Spain''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
− | |April 22, 2022 - April 22, 2023 | + | | April 22, 2022 - April 22, 2023 |
|- | |- | ||
− | | '''Amsterdam UMC''' | + | |'''Amsterdam UMC''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
− | |April 28, 2022 - April 28, 2023 | + | | April 28, 2022 - April 28, 2023 |
|- | |- | ||
− | | '''IZOTOPCENTRUM''' | + | |'''IZOTOPCENTRUM''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
− | |April 28, 2022 - April 28, 2023 | + | | April 28, 2022 - April 28, 2023 |
|- | |- | ||
− | | '''University Hospital Tübingen''' | + | | |
− | |FDG-PET/CT Profile (ver2016) | + | '''University Hospital Tübingen''' |
+ | | FDG-PET/CT Profile (ver2016) | ||
|May 2, 2022 - May 2, 2023 | |May 2, 2022 - May 2, 2023 | ||
|- | |- | ||
− | | '''x''' | + | |'''x''' |
− | |FDG-PET/CT Profile (ver2016) | + | | FDG-PET/CT Profile (ver2016) |
|May 2, 2022 - May 2, 2023 | |May 2, 2022 - May 2, 2023 | ||
|- | |- | ||
− | | '''x''' | + | |'''x''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
|May 00, 2022 - May 00, 2023 | |May 00, 2022 - May 00, 2023 | ||
|- | |- | ||
− | | '''x''' | + | |'''x''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
|May 00, 2022 - May 00, 2023 | |May 00, 2022 - May 00, 2023 | ||
|- | |- | ||
− | | '''x''' | + | |'''x''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
|May 00, 2022 - May 00, 2023 | |May 00, 2022 - May 00, 2023 | ||
|- | |- | ||
− | | '''x''' | + | |'''x''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
|May 00, 2022 - May 00, 2023 | |May 00, 2022 - May 00, 2023 | ||
|- | |- | ||
− | | '''x''' | + | |'''x''' |
|FDG-PET/CT Profile (ver2016) | |FDG-PET/CT Profile (ver2016) | ||
|May 00, 2022 - May 00, 2023 | |May 00, 2022 - May 00, 2023 | ||
|} | |} | ||
− | |||
Line 196: | Line 209: | ||
{| style="width:80%" border="1" cellpadding="3" | {| style="width:80%" border="1" cellpadding="3" | ||
− | ! <font color=green>'''Imaging Site/Vendor/CRO'''</font> | + | !<font color="green">'''Imaging Site/Vendor/CRO'''</font> |
− | ! <font color=green>'''QIBA Profile'''</font> | + | !<font color="green">'''QIBA Profile'''</font> |
− | ! <font color=green>'''Conformance Term'''</font> | + | !<font color="green">'''Conformance Term'''</font> |
|- | |- | ||
− | | '''Hospital Israelita Albert Einstein, Sao Paulo, Brazil''' | + | |'''Hospital Israelita Albert Einstein, Sao Paulo, Brazil''' |
− | | ADC Change Profile (ver2019) | + | |ADC Change Profile (ver2019) |
− | | April 1, 2020 – April 1, 2022 | + | |April 1, 2020 – April 1, 2022 |
|- | |- | ||
− | | '''New York-Presbyterian/Weill Cornell Medical Center''' | + | |'''New York-Presbyterian/Weill Cornell Medical Center''' |
− | | ADC Change Profile (ver2019) | + | |ADC Change Profile (ver2019) |
− | | April 1, 2021 – April 1, 2023 | + | |April 1, 2021 – April 1, 2023 |
|- | |- | ||
− | | '''AZ Groeninge''' | + | |'''AZ Groeninge''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | April 22, 2022 – April 22, 2023 | + | |April 22, 2022 – April 22, 2023 |
|- | |- | ||
− | | '''Klinikum Mutterhaus der Borromäerinnen''' | + | |'''Klinikum Mutterhaus der Borromäerinnen''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | April 22, 2022 – April 22, 2023 | + | |April 22, 2022 – April 22, 2023 |
|- | |- | ||
− | | '''IEO European Institute of Oncology''' | + | |'''IEO European Institute of Oncology''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | April 26, 2022 - April 26, 2023 | + | |April 26, 2022 - April 26, 2023 |
|- | |- | ||
− | | '''University of Pisa''' | + | |'''University of Pisa''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | April 26, 2022 - April 26, 2023 | + | |April 26, 2022 - April 26, 2023 |
|- | |- | ||
− | | '''Centre d'Imagerie Nucléaire d'Annecy''' | + | |'''Centre d'Imagerie Nucléaire d'Annecy''' |
− | | FDG-PET/CT Profile (ver2016) | + | |FDG-PET/CT Profile (ver2016) |
− | | September 19, 2022 - September 19, 2023 | + | |September 19, 2022 - September 19, 2023 |
|- | |- | ||
− | | '''Site''' | + | | '''Site''' |
− | | Profile (ver-year) | + | |Profile (ver-year) |
− | | dates active | + | |dates active |
|} | |} |
Revision as of 15:29, 19 May 2023
FULL PROFILE CONFORMANCE MARK
QIBA® Registered Conformance via Self-attestation
QIBA is offering a conformance service to help clinical sites demonstrate they can achieve high-quality quantitative imaging results. A clinical site that achieves QIBA Profile specifications will receive a QIBA Conformance Registered Mark that can be used to distinguish itself as performing quantitative imaging studies with high levels of precision. Scanner and analysis software vendors can also obtain the QIBA Registered Conformance Mark to demonstrate their specific medical device(s) or software has demonstrated conformance with a given QIBA Profile.
Sites in Full Conformance to a QIBA Profile
Imaging Site/Vendor/CRO | Pilot | QIBA Profile | Conformance Term |
---|---|---|---|
Invicro Imaging Center London | QIBA-EARL I | ADC Change Profile (ver2019) | April 8, 2020 - April 7, 2022 |
Liverpool Hospital, SWS Australia | QIBA-EARL I | ADC Change Profile (ver2019) | April 1, 2021 - April 1, 2023 |
University Hospital Olomouc | QIBA-EARL I | FDG-PET/CT Profile (ver2016) | February 15, 2021 - February 14, 2022 |
University College London Hospital | QIBA-EARL I | FDG-PET/CT Profile (ver2016) | February 15, 2021 - February 14, 2022 |
Charite University Medical Hospital Berlin | QIBA-EARL I | FDG-PET/CT Profile (ver2016) | February 15, 2021 - February 14, 2022 |
German Oncology Center (GOC), Cyprus | QIBA-EARL I | FDG-PET/CT Profile (ver2016) | May 28, 2021 - May 27, 2022 |
University Medical Center Groningen, NL | QIBA-EARL I | FDG-PET/CT Profile (ver2016) | May 28, 2021 - May 27, 2022 |
University of Duisburg-Essen, Germany | QIBA-EARL I | FDG-PET/CT Profile (ver2016) | May 28, 2021 - May 27, 2022 |
University Medical Center Amsterdam, NL | QIBA-EARL I | FDG-PET/CT Profile (ver2016) | May 28, 2021 - May 27, 2022 |
Kobe City General Hospital (KCGH), Japan | QIBA-EARL I | FDG-PET/CT Profile (ver2016) | May 28, 2021 - May 27, 2022 |
Klinik für Nuklearmedizin der TU München, Germany | QIBA-EARL I | FDG-PET/CT Profile (ver2016) | May 28, 2021 - May 27, 2022 |
Humanitas Istituto Clinico Catanese | QIBA-EARL I | FDG-PET/CT Profile (ver2016) | November 8, 2022 - November 8, 2023 |
QIBA-EARL Pilot II -- in progress
Imaging Site/Vendor/CRO | QIBA Profile | Conformance Term |
---|---|---|
CUH Alliance Medical | FDG-PET/CT Profile (ver2016) | March 31, 2022 – March 31, 2023 |
IRCCS Ospedale Policlinico San Martino di Genova | FDG-PET/CT Profile (ver2016) | March 31, 2022 – March 31, 2023 |
Institut Claudius REGAUD | FDG-PET/CT Profile (ver2016) | March 31, 2022 – March 31, 2023 |
Centro PET La Milagrosa | FDG-PET/CT Profile (ver2016) | March 31, 2022 – March 31, 2023 |
University Hospital Regensburg | FDG-PET/CT Profile (ver2016) | March 31, 2022 - March 31, 2023 |
INTECNUS | FDG-PET/CT Profile (ver2016) | March 31, 2022 - March 31, 2023 |
German Oncology Center (GOC), Cyprus | FDG-PET/CT Profile (ver2016) | March 31, 2022 - March 31, 2023 |
Affidea – CT Clinic | FDG-PET/CT Profile (ver2016) | March 31, 2022 - March 31, 2023 |
Hospital Regional Universitario de Málaga | FDG-PET/CT Profile (ver2016) | April 9, 2022 - April 9, 2023 |
IDI - Unitat MN-PET Hospital Universitari de Bellvitge | FDG-PET/CT Profile (ver2016) | April 14, 2022 - April 14, 2023 |
Affidea Warsaw 1 PET-CT Department | FDG-PET/CT Profile (ver2016) | April 14, 2022 - April 14, 2023 |
National Cancer Hospital (K hospital) | FDG-PET/CT Profile (ver2016) | April 14, 2022 - April 14, 2023 |
Klinikum rechts der Isar, Nuclear Medicine Department | FDG-PET/CT Profile (ver2016) | April 14, 2022 - April 14, 2023 |
IRMET PET/CT Centre | FDG-PET/CT Profile (ver2016) | April 14, 2022 - April 14, 2023 |
Semmelweis University Medical Imaging Clinic | FDG-PET/CT Profile (ver2016) | April 14, 2022 - April 14, 2023 |
Centro PET La Milagrosa | FDG-PET/CT Profile (ver2016) | April 14, 2022 - April 14, 2023 |
Lausanne University Hospital | FDG-PET/CT Profile (ver2016) | April 20, 2022 - April 20, 2023 |
University Hospital dr. Peset. Valencia, Spain | FDG-PET/CT Profile (ver2016) | April 22, 2022 - April 22, 2023 |
Amsterdam UMC | FDG-PET/CT Profile (ver2016) | April 28, 2022 - April 28, 2023 |
IZOTOPCENTRUM | FDG-PET/CT Profile (ver2016) | April 28, 2022 - April 28, 2023 |
University Hospital Tübingen |
FDG-PET/CT Profile (ver2016) | May 2, 2022 - May 2, 2023 |
x | FDG-PET/CT Profile (ver2016) | May 2, 2022 - May 2, 2023 |
x | FDG-PET/CT Profile (ver2016) | May 00, 2022 - May 00, 2023 |
x | FDG-PET/CT Profile (ver2016) | May 00, 2022 - May 00, 2023 |
x | FDG-PET/CT Profile (ver2016) | May 00, 2022 - May 00, 2023 |
x | FDG-PET/CT Profile (ver2016) | May 00, 2022 - May 00, 2023 |
x | FDG-PET/CT Profile (ver2016) | May 00, 2022 - May 00, 2023 |
PARTIAL PROFILE CONFORMANCE RIBBON
QIBA® Registered Conformance via Self-attestation
A clinical site that achieves a subset of QIBA Profile specifications will receive a QIBA Self-attestation Ribbon that can be used to distinguish itself as performing quantitative imaging studies with better than average levels of precision. Scanner and analysis software vendors can also obtain the QIBA Self-attestation Ribbon to demonstrate their specific medical device(s) or software has been tested and has demonstrated partial conformance with a given QIBA Profile.
Imaging Site/Vendor/CRO | QIBA Profile | Conformance Term |
---|---|---|
Hospital Israelita Albert Einstein, Sao Paulo, Brazil | ADC Change Profile (ver2019) | April 1, 2020 – April 1, 2022 |
New York-Presbyterian/Weill Cornell Medical Center | ADC Change Profile (ver2019) | April 1, 2021 – April 1, 2023 |
AZ Groeninge | FDG-PET/CT Profile (ver2016) | April 22, 2022 – April 22, 2023 |
Klinikum Mutterhaus der Borromäerinnen | FDG-PET/CT Profile (ver2016) | April 22, 2022 – April 22, 2023 |
IEO European Institute of Oncology | FDG-PET/CT Profile (ver2016) | April 26, 2022 - April 26, 2023 |
University of Pisa | FDG-PET/CT Profile (ver2016) | April 26, 2022 - April 26, 2023 |
Centre d'Imagerie Nucléaire d'Annecy | FDG-PET/CT Profile (ver2016) | September 19, 2022 - September 19, 2023 |
Site | Profile (ver-year) | dates active |